The landscape of dementia analysis has developed significantly with the arrival of complex biomarkers, including amyloid PET scans, tau imaging, and blood-based mostly assessments which will detect Alzheimer's pathology decades prior to signs emerge. Although these technological advancements characterize extraordinary development in understanding n